Delay in diagnostic workup and treatment of esophageal cancer

Journal of Gastrointestinal Surgery

Volumn 14, Issue 3, 2010, Pages 476-483

  Grotenhuis, Brechtje A ^a   van Hagen, Pieter ^a   Wijnhoven, Bas P L ^a   Spaander, Manon C W ^a   Tilanus, Hugo W ^a   van Lanschot, Jan J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Delay; Diagnostic workup; Esophageal cancer; Survival; Waiting list

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DELAYED DIAGNOSIS; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATIENT REFERRAL; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; DELAYED DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WAITING LISTS;

EID: 77950516610     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1109-y     Document Type: Article

References (21)

1. Lerut T, De Leyn P, Coosemans W et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216(5): 583-590.
2. Siewert JR, Stein HJ, Feith M et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1, 000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234(3): 360-367. (discussion 368-369).
3. Hulscher JB, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347(21): 1662-1669.
4. Eloubeidi MA, Desmond R, Arguedas MR et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U. S.: the importance of tumor length and lymph node status. Cancer 2002; 95(7): 1434-1443.
5. Wijnhoven BP, Tran KT, Esterman A et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007; 245(5): 717-725.
6. Richards MA, Westcombe AM, Love SB et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999; 353(9159): 1119-1126.
7. Ramos M, Esteva M, Cabeza E et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007; 43(17): 2467-2478.
8. Ramos M, Esteva M, Cabeza E et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008; 44(4): 510-521.
9. Wang J, Liu F, Gao H et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus. Jpn J Clin Oncol 2008; 38(2): 87-91.
10. Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer 2006; 95(7): 835-840.
11. Rothwell JF, Feehan E, Reid I et al. Delay in treatment for oesophageal cancer. Br J Surg 1997; 84(5): 690-693.
12. Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 1997; 314(7079): 467-470.
13. Witzig R, Schonberger B, Fink U et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 2006; 38(11): 1122-1126.
14. Kok TC, van Lanschot JJB, Siersema PD et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997; 17: 984.
15. van Heijl M, van Lanschot JJ, Koppert LB et al. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008; 8: 21.
16. Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007; 246(6): 992-1000. (discussion 1000-1001).
17. Sobin L. TNM classification of malignant tumors, 6th edn. Wiley: New York, 2002.
18. Visser MR, van Lanschot JJ, van der Velden J et al. Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol 2006; 93(7): 571-577.
19. Logan RF, Behan MW, Campion G, Keating NA. Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003; 3(4): 386-387.
20. Spahos T, Hindmarsh A, Cameron E et al. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J 2005; 81(961): 728-730.
21. Rachet B, Maringe C, Nur U et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009; 10(4): 351-369.